Healthcare ❯ Pharmaceuticals ❯ Drug Approval

FDA Regulations

Clinical Trials Chronic Kidney Disease Compounding Drugs Off-Label Use Addyi Hypertension Treatments Clinical Research Abbreviated New Drug Application Wegovy Leqembi Semaglutide Eli Lilly Medication Access

10 ARTICLES

2mo ago

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

The court said routine FDA-compliant labels and ordinary marketing do not by themselves prove inducement and set a higher bar requiring clear affirmative steps to encourage patented uses.

4 ARTICLES

5mo ago

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

3 ARTICLES

6mo ago

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

7 ARTICLES

7mo ago

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65